After uniQure (QURE) announced they have achieved alignment with the FDA on key elements of an accelerated approval pathway for AMT-130, Stifel said this “looks like a best-case scenario,” noting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback